Determination of Biomarker for Progression and Immunity Status of Patients with Type II Diabetes Mellitus as Comorbid of Covid-19

Determination of Biomarker for Progression and Immunity Status of Patients with Type II Diabetes Mellitus as Comorbid of Covid-19

3
Aug
2022

Indonesia is ranked 5th in terms of the highest number of Diabetes Mellitus (DM) sufferers in the world. DM is the main co-morbid of cytokine storms that lead to poor Covid-19 outcomes. Advance Glycation End Products (AGEs) are the end products of protein glycation under conditions of hyperglycemia,  which are suspected to play an important role in the pathogenesis of DM complications, while Extracellular Traps (ETs) are products of immune cells that play a role in the immune response against pathogens, also trigger blood clots and tissue damage.

submitted by admin

Pages